Discover 715 paid clinical trials in Olathe, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 715
Active & Responsive
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
Location: Kansas City KS, O'Fallon IL, Winston-Salem NC,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06538064
Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: Kansas City MO, Wichita KS, Flossmoor IL, Hazelwood MO,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT06628908
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Westwood KS, Wichita KS, Omaha NE, St Louis MO,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06982521
Phase 3, Recruiting
Active & Responsive
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
for
Metastatic Breast Cancer
Location: Westwood KS, Memphis TN, Dyer IN, Munster IN,
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 60+
Code: NCT06377852
Phase 3, Recruiting
Active & Responsive
Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
for
Acute Myeloid Leukemia, Chronic Myeloid Leukemia,
Location: Westwood KS, Columbus OH
Sponsor: University of Kansas Medical Center
Sex: All
Age: 18 - 65
Code: NCT03533816
Phase 1, Recruiting
Active & Responsive
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
for
Gastric Adenocarcinoma,
Location: Westwood KS, Chicago IL, Dallas TX, Milwaukee WI,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT05365581
Phase 1, Recruiting
Active & Responsive
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer,
Location: Westwood KS, Omaha NE, Iowa City IA,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT06901531
Phase 3, Recruiting
Active & Responsive
Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients
for
NSCLC, Stage III, Locally Advanced Lung Carcinoma
Location: Kansas City KS
Sponsor: Jun Zhang, MD, PhD
Sex: All
Age: 18+
Code: NCT04680377
Recruiting
Active & Responsive
Efficacy of Point Of Service Testing in MBC
for
Metastatic Cancer, Breast Cancer
Location: Kansas City KS
Sponsor: University of Kansas Medical Center
Sex: All
Age: 18+
Code: NCT03983577
Recruiting
Active & Responsive
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
for
Advanced Melanoma
Location: Westwood KS, St Louis MO, Oklahoma City OK,
Sponsor: Immunocore Ltd
Sex: All
Age: 18+
Code: NCT05549297
Phase 3, Recruiting
Active & Responsive
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.
for
Spasticity
Location: Overland Park KS, Dallas TX, Elkins Park PA, Downey CA
Sponsor: Ipsen
Sex: All
Age: 18 - 70
Code: NCT04752774
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors, Genital Neoplasm, Female,
Location: Kansas City KS, Madison WI, Nashville TN, Columbus OH,
Sponsor: Marengo Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05592626
Phase 1, Phase 2, Recruiting
Active & Responsive
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
for
Breast Atypical Hyperplasia, Breast Carcinoma,
Location: Kansas City KS, Ann Arbor MI, Columbus OH
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 45 - 70+
Code: NCT06195306
Phase 2, Recruiting
Active & Responsive
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
for
Breast Atypical Hyperplasia, Breast Carcinoma,
Location: Kansas City KS, Chicago IL, Columbus OH, Duarte CA
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 35+
Code: NCT05941520
Phase 2, Recruiting
Active & Responsive
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
for
Lymphoma, Non-Hodgkin, B-cell Lymphoma,
Location: Kansas City KS, Iowa City IA, Rochester MN, Chicago IL,